Els oncomicrobiòtics i la influència de la microbiota en la carcinogènesi
Microbiota result from a symbiotic union between a host and certain microorganisms, helping to preserve the balance between human health and disease, as they directly influence the host's metabolic, inflammatory and immune functions. The constant interaction between intestinal microbiota, the c...
| Autores: | , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2021 |
| País: | España |
| Institución: | Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya) |
| Repositorio: | Recercat. Dipósit de la Recerca de Catalunya |
| OAI Identifier: | oai:recercat.cat:2445/195375 |
| Acceso en línea: | https://hdl.handle.net/2445/195375 |
| Access Level: | acceso abierto |
| Palabra clave: | Carcinogènesi Microbiota intestinal Carcinogenesis Gastrointestinal microbiome |
| Sumario: | Microbiota result from a symbiotic union between a host and certain microorganisms, helping to preserve the balance between human health and disease, as they directly influence the host's metabolic, inflammatory and immune functions. The constant interaction between intestinal microbiota, the cells of the immune system, and the epithelium maintains intestinal homeostasis. This paper explains the scientific evidence supporting microbial influence in carcinogenesis, tumour progression, and the therapeutic efficacy of cancer drugs. Finally, it outlines the new challenges faced in therapeutics to enhance specific microbiota based on the therapeutic effectiveness needed. |
|---|